NPPB and angina pectoris: Thus, the present study aimed to assess whether CTO-PCI in patients with chronic heart failure and reduced ejection fraction (HFrEF) is associated with an improvement in LVEF, angina status, New York Heart Association (NYHA) functional class for dyspnea (NYHA I-IV) and brain natriuretic peptide (BNP) levels.